Drugs / Monteplase
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00442234 | May 2007 → Apr 2008 | pulmonary embolism | Eisai Inc. | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Monteplase | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00442234 ↗ |
| Known as | Cleactor | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108426 ↗ |
| Known as | Monteplasa | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108426 ↗ |
| Modality | Protein / enzyme biologic | — CHEMBL2108426 ↗ |
| Target | PLAT | “Tissue-type plasminogen activator exogenous protein” CHEMBL2108426 ↗ |